After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.
F0101B) and Mouse Anti-Human CD3e PE-conjugated Monoclonal Antibody (Catalog # FAB100P). Quadrant markers were set based on control antibody staining (Catalog # MAB002)." class="big_lightbox" target="_blank">
165-B7) is immobilized at 0.5 µg/mL, Recombinant Human ICOS (Catalog # 9865-CS) binds with an ED50 of 25-125 ng/mL." class="big_lightbox" target="_blank">
The C398.4A antibody reacts with the human, mouse and rat 47-57 kD ICOS protein, also known as inducible costimulatory molecule and H4. This protein is homologous to the CD28/CTLA-4 proteins. ICOS is expressed on activated T cells and a subset of thymocytes. It is able to costimulate T cells proliferation. In addition, ICOS is involved in humoral immune responses (B cell germinal center formation). The ICOS ligand is B7h/B7RP-1 or B7-H2. ICOS stimulation has been shown to potentiate TCR-mediated IL-4 and IL-10 production and has been proposed to play a role in Th2 cell development. The C398.4A antibody is useful for flow cytometric analysis and is able to costimulate T cell activation and proliferation.
![N/A ICOS [Biotin]](http://images.novusbio.com/fullsize/elisa/DATA_ICOS_DY169_ELISA_1698.jpg)
![Bioactivity ICOS [Unconjugated]](http://images.novusbio.com/images/protein/ICOS_169CS_2302.jpg)
![Binding Activity ICOS [Unconjugated]](http://images.novusbio.com/images/protein/ICOS_9865CS_1967.jpg)
![SDS-Page ICOS [Unconjugated]](http://images.novusbio.com/fullsize/protein/ICOS_9865CS_1947.jpg)
